Copyright
©The Author(s) 2020.
World J Gastroenterol. Jun 7, 2020; 26(21): 2810-2820
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2810
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2810
Figure 4 Gan Shen Fu Fang reduced extracellular signal-regulated kinase phosphorylation and NF-κB expression in common bile duct-ligated rats and HSC-T6 cells.
A-D: Liver tissue homogenates were subjected to immunoblotting as indicated. Representative bans and quantitative data are shown. N = 4; E-G: HSC-T6 cells were not stimulated, and whole-cell lysates were used. Representative images and quantitative data are shown; H: HSC-T6 cells were stimulated with platelet-derived growth factor-BB to further evaluate the effect of GSFF on extracellular signal-regulated kinase phosphorylation. aP < 0.05, bP < 0.01, eP < 0.001, compared with control cells; cP < 0.05, dP < 0.01, fP < 0.001 compared with sham rats. gP < 0.05, hP < 0.01 compared with the 2W-CBDL rats; iP < 0.05, lP < 0.001, compared with the 4W-CBDL rats; nP <0.01, compared with cells stimulated with only platelet-derived growth factor-BB. PDGF: Platelet-derived growth factor; GSFF: Gan Shen Fu Fang; ERK: Extracellular signal-regulated kinase; CBDL: Common bile duct-ligated.
- Citation: Du QH, Zhang CJ, Li WH, Mu Y, Xu Y, Lowe S, Han L, Yu X, Wang SY, Li Y, Li J. Gan Shen Fu Fang ameliorates liver fibrosis in vitro and in vivo by inhibiting the inflammatory response and extracellular signal-regulated kinase phosphorylation. World J Gastroenterol 2020; 26(21): 2810-2820
- URL: https://www.wjgnet.com/1007-9327/full/v26/i21/2810.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i21.2810